Researchers at Van Andel Institute developed a more effective early-stage pancreatic cancer blood test.

Researchers at the Van Andel Institute have developed a promising blood test that detects early-stage pancreatic cancer more effectively than existing methods. By combining two biomarkers, CA199.STRA and CA19-9, the test improved detection accuracy by 27%, identifying 71% of pancreatic cancer samples in lab tests. The next phase involves clinical evaluations, as early detection is crucial for improving survival rates.

October 04, 2024
6 Articles

Further Reading